Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 503135649

Selleck Chemical LLC Polatuzumab vedotin-piiq-1MG
SDP

Catalog No. 503135649
Encompass_Preferred

Polatuzumab vedotin-piiq (polatuzumab vedotin DCDS4501A RG7596) is an antibody-drug conjugate (ADC) composed of a monoclonal antibody against CD79b (a B cell receptor component) and the anti-mitotic cytotoxic agent monomethyl auristatin (MMAE) It is used for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL)

Catalog No. 50-313-5649 Supplier Selleck Chemical LLC Supplier No. D40121MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Polatuzumab vedotin-piiq (polatuzumab vedotin DCDS4501A RG7596) is an antibody-drug conjugate (ADC) composed of a monoclonal antibody against CD79b (a B cell receptor component) and the anti-mitotic cytotoxic agent monomethyl auristatin (MMAE) It is used for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL)

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.